The objective: to evaluate the clinical effectiveness of treatment of patients with scleroatrophic lichen of the penis using intrafocal injection of a suspension which contains 0.4% triamcinolone acetonide.
Materials and methods. 25 patients with scleroatrophic lichen of the penis participated in the study. The average age of men was 34.1±5.7 years, the duration of the disease was 1.1±0.3 years. Patients were divided into two groups: 11 patients of the I group were prescribed external ointment with 0.05% clobetasol propionate twice a day for 3 months; 14 patients of the II group received an ointment containing 0.05% clobetasol propionate twice a day for 3 months, and a suspension with 0.4% triamcinolone acetonide was administered intradermally in lesions once every 3 weeks for 3 months.
For clinical diagnosis verification, an incisional biopsy of the skin from the lesion was performed in 6 patients, followed by a histological examination.
The clinical effectiveness of therapy was assessed after 1, 2 and 3 months according to the following criteria: size, color and number of lesions. The time of complete clinical remission onset was also evaluated.
Results. After 3 months of intralesional administration of a suspension containing 0.4% triamcinolone acetonide in patients with lichen sclerosus together with the external use of an ointment containing 0.05% clobetasol propionate, better treatment results were found in patients of the II group (p=0.046). Clinical remission was registered in 50.0% and 9.1% of patients in the II and I groups, respectively; significant improvement – in 35.7% and 27.2%; improvement – in 14.3% and 45.5%; no changes – 0% and 18.2% of patients in the II and I groups, respectively.
Conclusions. Treatment of patients with scleroatrophic lichen of the penis with the use of intrafocal injection of a suspension containing 0.4% triamcinolone acetonide together with the external use of an ointment containing 0.05% clobetasol propionate ensures the achievement of clinical remission in 50.0% of patients after 3 months and a significant improvement in the condition of the skin in the lesions – in 35.7%.
Interdisciplinary management of patients with scleroatrophic lichen by dermatovenerologists and urologists is important for long-term control of the disease.